AlphaFold predicted structure
SYNGAP1 · Q96PV0

Mean pLDDT
59.2/ 100
Low
1,343 residues
Confidence breakdown
- Very high(≥ 90)22%
- Confident(70–90)20%
- Low(50–70)9%
- Very low(< 50)50%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
synaptic Ras GTPase activating protein 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedHereditary ataxia with onset in adulthood
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownintellectual disability, autosomal dominant 5
complex neurodevelopmental disorder
hereditary disease
Intellectual disability
Seizure
Epileptic encephalopathy
neurodevelopmental disorder
epilepsy with myoclonic atonic seizures
Global developmental delay
developmental disability
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Ras/Rap GTPase-activating protein SynGAP
Major constituent of the PSD essential for postsynaptic signaling. Inhibitory regulator of the Ras-cAMP pathway. Member of the NMDAR signaling complex in excitatory synapses, it may play a role in NMDAR-dependent control of AMPAR potentiation, AMPAR membrane trafficking and synaptic plasticity. Regulates AMPAR-mediated miniature excitatory postsynaptic currents. Exhibits dual GTPase-activating specificity for Ras and Rap. May be involved in certain forms of brain injury, leading to long-term learning and memory deficits (By similarity)
Curated MONDO disease pages that list SYNGAP1 among their top associated genes.
SYNGAP1 · Q96PV0

Mean pLDDT
59.2/ 100
Low
1,343 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0